相关实验视频

Updated: Jan 10, 2026

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

口服免疫疗法诱导IncRNA表达的转变调节过敏原特定免疫反应

Olivia Liong¹, Kati Palosuo², Victoria Hinkkanen¹

¹Human Microbiome (HUMI) Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland.

|November 29, 2025

概括

对蛋过敏的口服免疫疗法 (OIT) 对长期非编码RNA (lncRNA) 表达有影响. 特定的lncRNA与免疫路径相关,这表明它在脱敏和潜在的治疗点中发挥了作用.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

卵口服免疫疗法 (OIT) 成功缓解过敏儿童的饮食限制.
OIT与外周血液单核细胞 (PBMC) 中炎症减少和基因表达改变有关.

研究的目的:

调查长非编码RNAs (lncRNAs) 在卵子OIT期间免疫反应中的作用.
在OIT之后,确定调节过敏原特异性免疫反应的lncRNAs.

主要方法:

对接受OIT的儿童的PBMC转录组数据的分析.
同表达基因模块的识别和通路丰富分析.
在PBMC和THP1细胞的体外刺激以评估lncRNA功能.

主要成果:

十七个lncRNA与IL-13,IL-4和IL-10信号通路正相关.
这些lncRNA与参与中性粒细胞脱粒和热的途径负相关.
在刺激的免疫细胞中,lncRNA LOC644727表达与CXCL8相关.

结论:

lncRNAs参与调节卵子过敏的OIT期间的基因表达.
LOC644727显示出作为炎症反应生物标志物的潜力.
针对 lncRNAs 可能为 OIT 脱敏化协议提供新的治疗策略.

关键词:

脱敏感化脱敏感化蛋过敏是因为蛋过敏.在ncRNA中,我们可以网络分析网络分析口服免疫疗法是口服免疫疗法.

更多相关视频

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue NALT in Mouse Responses to Vaccines

Examining the Role of Nasopharyngeal-associated Lymphoreticular Tissue NALT in Mouse Responses to Vaccines

Published on: August 1, 2012

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

Published on: May 10, 2022

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.